The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-12-14
DOI
10.3389/fphar.2022.1090237
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Corrigendum to “siRNA: Mechanism of action, challenges, and therapeutic approaches” [Eur. J. Pharmacol. 905 (2021) 174178]
- (2022) Walhan Alshaer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease
- (2022) Brian Tomlinson et al. Expert Opinion on Drug Metabolism & Toxicology
- Non-viral vectors for RNA delivery
- (2022) Yi Yan et al. JOURNAL OF CONTROLLED RELEASE
- Drug delivery systems for RNA therapeutics
- (2022) Kalina Paunovska et al. NATURE REVIEWS GENETICS
- Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
- (2022) David Adams et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Pharmacokinetic and Pharmacodynamic Modeling of siRNA Therapeutics – a Minireview
- (2022) Jae Yoon Jeon et al. PHARMACEUTICAL RESEARCH
- Vutrisiran: First Approval
- (2022) Susan J. Keam DRUGS
- The growth of siRNA-based therapeutics: updated clinical studies
- (2021) M. May Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Lumasiran: First Approval
- (2021) Lesley J. Scott et al. DRUGS
- Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs
- (2021) Shintaro Fumoto et al. Pharmaceutics
- Overcoming barriers by local drug delivery with liposomes
- (2021) S.G. Antimisiaris et al. ADVANCED DRUG DELIVERY REVIEWS
- Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
- (2021) Kiara Fairman et al. BIOCHEMICAL PHARMACOLOGY
- Inclisiran: First Approval
- (2021) Yvette N. Lamb DRUGS
- Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic
- (2021) Annette I.S. van den Berg et al. JOURNAL OF CONTROLLED RELEASE
- Structural tuning of oligonucleotides for enhanced blood circulation properties of unit polyion complexes prepared from two-branched poly(ethylene glycol)-block-poly(l-lysine)
- (2021) Mitsuru Naito et al. JOURNAL OF CONTROLLED RELEASE
- Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran – results of the phase 1 inhibitor cohort
- (2021) K. John Pasi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Advances in siRNA delivery strategies for the treatment of MDR cancer
- (2021) Md Abdus Subhan et al. LIFE SCIENCES
- Therapeutic RNA Delivery for COVID and Other Diseases
- (2021) Curtis Dobrowolski et al. Advanced Healthcare Materials
- Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins
- (2021) Yaxian Zhou et al. ACS Central Science
- Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
- (2021) Basmah N. Aldosari et al. Pharmaceutics
- Cytosolic Delivery of Nucleic Acids: The case of Ionizable Lipid Nanoparticles
- (2021) Michele Schlich et al. Bioengineering & Translational Medicine
- Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
- (2021) Zehua Liu et al. ADVANCED DRUG DELIVERY REVIEWS
- A Critical Review of the Efficacy and Safety of Inclisiran
- (2021) Jennifer Hardy et al. American Journal of Cardiovascular Drugs
- Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to GalNAc and the Tumor-Associated Tn Antigen
- (2021) Adele Gabba et al. BIOCHEMISTRY
- Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1
- (2021) Yaacov Frishberg et al. Clinical Journal of the American Society of Nephrology
- Impact of lipid nanoparticle size on mRNA vaccine immunogenicity
- (2021) Kimberly J. Hassett et al. JOURNAL OF CONTROLLED RELEASE
- Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
- (2021) Sander F. Garrelfs et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interspecies Scaling of Human Clearance and Plasma Trough Exposure for Antisense Oligonucleotides: A Retrospective Analysis of Triantennary N-Acetyl Galactosamine-Conjugated and Unconjugated-Antisense Oligonucleotides
- (2021) Charvi Nanavati et al. Nucleic Acid Therapeutics
- Insight Into the Prospects for RNAi Therapy of Cancer
- (2021) Zhili Tian et al. Frontiers in Pharmacology
- The Limitless Future of RNA Therapeutics
- (2021) Tulsi Ram Damase et al. Frontiers in Bioengineering and Biotechnology
- From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies
- (2021) Hironori Adachi et al. Biomedicines
- Renal Function Decline With Small Interfering RNA Silencing Aminolevulinic Acid Synthase 1 (ALAS1)
- (2021) Hélène Lazareth et al. Kidney International Reports
- Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases
- (2021) Elias Fattal et al. ADVANCED DRUG DELIVERY REVIEWS
- Nucleic Acid Delivery for Therapeutic Applications
- (2021) Akash Gupta et al. ADVANCED DRUG DELIVERY REVIEWS
- siRNA enrichment in Argonaute 2-depleted Blattella germanica
- (2021) José Carlos Montañés et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Lipids and Lipid Derivatives for RNA Delivery
- (2021) Yuebao Zhang et al. CHEMICAL REVIEWS
- Liposome-based delivery of biological drugs
- (2021) Kosheli Thapa Magar et al. CHINESE CHEMICAL LETTERS
- Minimal physiologically based pharmacokinetic-pharmacodynamic (mPBPK-PD) model of GalNAc-conjugated siRNA disposition and gene silencing in preclinical species and humans
- (2021) Vivaswath S Ayyar et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Ligand conjugate SAR and enhanced delivery in NHP
- (2021) Richard James Holland et al. MOLECULAR THERAPY
- The current landscape of nucleic acid therapeutics
- (2021) Jayesh A. Kulkarni et al. Nature Nanotechnology
- mRNA vaccines for infectious diseases: principles, delivery and clinical translation
- (2021) Namit Chaudhary et al. NATURE REVIEWS DRUG DISCOVERY
- Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing
- (2021) Hartmut Jahns et al. NUCLEIC ACIDS RESEARCH
- Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
- (2021) Ai-Ming Yu et al. PHARMACOLOGY & THERAPEUTICS
- The development and improvement of ribonucleic acid therapy strategies
- (2021) Yuxi Zhao et al. Molecular Therapy-Nucleic Acids
- Recent Advances in the Delivery Carriers and Chemical Conjugation Strategies for Nucleic Acid Drugs
- (2021) Shota Oyama et al. Cancers
- Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
- (2021) Hao Cui et al. ACS Omega
- Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration
- (2021) Manuel J. Carrasco et al. Communications Biology
- The Crystalline Nephropathies
- (2021) Mark A. Perazella et al. Kidney International Reports
- Chemistry of Lipid Nanoparticles for RNA Delivery
- (2021) Yulia Eygeris et al. ACCOUNTS OF CHEMICAL RESEARCH
- Lipid Nanoparticle–mRNA Formulations for Therapeutic Applications
- (2021) Chang Wang et al. ACCOUNTS OF CHEMICAL RESEARCH
- Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles
- (2021) Jing Wang et al. ADVANCED DRUG DELIVERY REVIEWS
- Inclisiran in lipid management: A Literature overview and future perspectives
- (2021) Pietro Scicchitano et al. BIOMEDICINE & PHARMACOTHERAPY
- Opportunities for innovation: Building on the success of lipid nanoparticle vaccines
- (2021) Jessica Huang et al. CURRENT OPINION IN COLLOID & INTERFACE SCIENCE
- The nano delivery systems and applications of mRNA
- (2021) Mingyuan Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines
- (2021) Anna K. Blakney et al. JOURNAL OF CONTROLLED RELEASE
- Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study
- (2021) Paolo Ventura et al. LIVER INTERNATIONAL
- Life of RISC: Formation, action, and degradation of RNA-induced silencing complex
- (2021) Hiro-oki Iwakawa et al. MOLECULAR CELL
- Overcoming GNA/RNA base-pairing limitations using isonucleotides improves the pharmacodynamic activity of ESC+ GalNAc-siRNAs
- (2021) Mark K Schlegel et al. NUCLEIC ACIDS RESEARCH
- GalNAc-siRNA conjugates: Prospective tools on the frontier of anti-viral therapeutics
- (2021) Lokesh Thangamani et al. PHARMACOLOGICAL RESEARCH
- Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection
- (2021) Sneha V. Gupta et al. DRUGS IN R&D
- Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
- (2021) Chandni Bardolia et al. Frontiers in Cardiovascular Medicine
- Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid (siRNA), Givosiran, in Patients with Acute Hepatic Porphyria
- (2020) Sagar Agarwal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach
- (2020) Franziska Freitag et al. ADVANCED DRUG DELIVERY REVIEWS
- Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects
- (2020) Bahru A. Habtemariam et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Statins and PCSK9 inhibitors: A new lipid-lowering therapy
- (2020) Enrique Gallego-Colon et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
- (2020) Alexandre J. Debacker et al. MOLECULAR THERAPY
- LB002ILLUMINATE-A, A PHASE 3 STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC, IN CHILDREN AND ADULTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1)
- (2020) Sander Garrelfs et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
- (2020) Manisha Balwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran as Adjunct Lipid-Lowering Therapy for Patients with Cardiovascular Disease: A Cost-Effectiveness Analysis
- (2020) Ning Kam et al. PHARMACOECONOMICS
- S1154 Clinical Outcomes in Patients With Acute Hepatic Porphyria Treated With Givosiran Who Stopped Hemin Prophylaxis at Study Entry: A Post Hoc Analysis of Data From the Phase 3 ENVISION Study Through Month 12
- (2020) Herbert L. Bonkovsky et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
- (2020) Christopher R Brown et al. NUCLEIC ACIDS RESEARCH
- Prolonged cultured human hepatocytes as an in vitro experimental system for the evaluation of potency and duration of activity of RNA therapeutics: Demonstration of prolonged duration of gene silencing effects of a GalNAc-conjugated human hypoxanthine phosphoribosyl transferase (HPRT1) siRNA
- (2020) Qian Yang et al. BIOCHEMICAL PHARMACOLOGY
- To Conjugate or to Package? A Look at Targeted siRNA Delivery Through Folate Receptors
- (2020) Lidya Salim et al. Nucleic Acid Therapeutics
- Bioconjugated oligonucleotides: recent developments and therapeutic applications
- (2019) sebastien benizri et al. BIOCONJUGATE CHEMISTRY
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- RNAi therapeutic and its innovative biotechnological evolution
- (2019) Yuhua Weng et al. BIOTECHNOLOGY ADVANCES
- siRNA therapeutics: a clinical reality
- (2019) Phei Er Saw et al. Science China-Life Sciences
- Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application
- (2019) Sikandar Hayat Khan Molecular Therapy-Nucleic Acids
- Lipid-based nanoparticle formulations for small molecules and RNA drugs
- (2019) Ludger M. Ickenstein et al. Expert Opinion on Drug Delivery
- Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9
- (2019) Charles A. German et al. BIODRUGS
- Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran
- (2019) Pedro Renato de Paula Brandão et al. Molecular Diagnosis & Therapy
- Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis
- (2019) Jessica E. Sutherland et al. Nucleic Acid Therapeutics
- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression
- (2018) Jennifer L.S. Willoughby et al. MOLECULAR THERAPY
- Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
- (2018) Donald J. Foster et al. MOLECULAR THERAPY
- Defense Mechanisms against Viral Infection in Drosophila: RNAi and Non-RNAi
- (2018) Luc Swevers et al. Viruses-Basel
- Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity
- (2018) Maja M. Janas et al. Nature Communications
- Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don’t
- (2018) R.L. Juliano Nucleic Acid Therapeutics
- GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
- (2018) Aaron D. Springer et al. Nucleic Acid Therapeutics
- Circular siRNAs for Reducing Off-Target Effects and Enhancing Long-Term Gene Silencing in Cells and Mice
- (2018) Liangliang Zhang et al. Molecular Therapy-Nucleic Acids
- Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape
- (2018) Anna Lechanteur et al. Nanomaterials
- Gene Silencing using siRNA for Preventing Liver Ischaemia-Reperfusion Injury
- (2018) H. Susana Marinho et al. CURRENT PHARMACEUTICAL DESIGN
- Patisiran: First Global Approval
- (2018) Sheridan M. Hoy DRUGS
- The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies
- (2018) Maja M. Janas et al. TOXICOLOGIC PATHOLOGY
- Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial
- (2018) Lawrence A. Leiter et al. DIABETES CARE
- Porphyria
- (2017) D. Montgomery Bissell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
- (2017) Jayaprakash K. Nair et al. NUCLEIC ACIDS RESEARCH
- An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria
- (2016) Abigail Liebow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1
- (2016) Chaitali Dutta et al. MOLECULAR THERAPY
- Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics
- (2016) Peter Lönn et al. Scientific Reports
- siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
- (2015) Shigeo Matsuda et al. ACS Chemical Biology
- Oligonucleotide Therapies: The Past and the Present
- (2015) Karin E. Lundin et al. HUMAN GENE THERAPY
- Role of Heme in Cardiovascular Physiology and Disease
- (2015) K. T. Sawicki et al. Journal of the American Heart Association
- Renaissance of mammalian endogenous RNAi
- (2014) Petr Svoboda FEBS LETTERS
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
- (2013) Jerome Gilleron et al. NATURE BIOTECHNOLOGY
- Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30)
- (2010) Gösta Holmgren et al. CLINICAL GENETICS
- CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARY: Drug Delivery Trends in Clinical Trials and Translational Medicine: Challenges and Opportunities in the Delivery of Nucleic Acid-Based Therapeutics
- (2010) Long Xu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started